IPATF .495 - building a sizeable position. This obscure biotech is grabbing sparse interest while it is on both of the lists below? https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1 https://twitter.com/wildcat2013/status/1235044370316853251/photo/1